SCHEMBL3885557

SCHEMBL3885557

Cc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)no1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.55
LMNA P02545 1/20 0.55
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TSHR P16473 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
PPIA P62937 1/20 0.48
TP53 P04637 2/20 0.47
THRB P10828 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTT P42858 1/20 0.47
TBXA2R P21731 2/20 0.46
ALDH1A1 P00352 3/20 0.46
GAA P10253 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3893550 0.85 MAPT (0.53) MAPTLMNAMEN1KMT2ATSHR
SCHEMBL6568083 0.72 ALDH1A1 (0.54) LMNAKMT2ATSHRNPSR1CYP1A2
SCHEMBL9754552 0.72 MEN1 (0.84) LMNAMEN1KMT2ATSHRNPSR1
SCHEMBL28897034 0.72 ALDH1A1 (0.84) MAPTLMNAMEN1KMT2ATSHR
SCHEMBL3889419 0.70 S1PR1 (0.48) MAPTLMNAMEN1KMT2ATSHR
SCHEMBL11883523 0.70 CA1 (0.68) MAPTLMNAMEN1KMT2ATSHR
SCHEMBL66631 0.70 TSHR (0.62) MAPTMEN1KMT2ATSHRNPSR1
SCHEMBL9131036 0.70 TBXA2R (0.82) MEN1KMT2ATP53TBXA2RALDH1A1
SCHEMBL9754483 0.70 MEN1 (0.75) LMNAMEN1KMT2ATP53HTT
SCHEMBL13188926 0.69 HRH3 (0.41) MAPTLMNACYP2D6ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013184-A1 SULFONAMIDE COMPOUNDS USEFUL AS EDG RECEPTOR MODULATORS AstraZeneca AB (SE) 2009-01-14 EP disclosed
WO-2007129019-A1 SULFONAMIDE COMPOUNDS USEFUL AS EDG RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2007-11-15 WO disclosed